A randomised, double-blind, parallel-group, phase 1 study comparing the pharmacokinetics, safety and efficacy of ct-p13 and infliximab in patients with active ankylosing spondylitis: 54 week results from the planetas study

dc.contributor.author	BLANCO GARCIA, FRANCISCO JAVIER
dc.date.accessioned	2017-06-07T07:00:21Z
dc.date.available	2017-06-07T07:00:21Z
dc.date.issued	2013
dc.identifier.issn	0003-4967
dc.identifier.uri	http://hdl.handle.net/20.500.11940/1569
dc.language.iso	eng
dc.title	A randomised, double-blind, parallel-group, phase 1 study comparing the pharmacokinetics, safety and efficacy of ct-p13 and infliximab in patients with active ankylosing spondylitis: 54 week results from the planetas study
dc.type	Publicación de congreso
dc.authorsophos	Park, W.
dc.authorsophos	Jaworski, J.
dc.authorsophos	Brzezicki, J.
dc.authorsophos	Gnylorybov, A.
dc.authorsophos	Kadinov, V.
dc.authorsophos	Sariego, I. G.
dc.authorsophos	Abud-Mendoza, C.
dc.authorsophos	Escalante, W. J. O.
dc.authorsophos	Kang, S. W.
dc.authorsophos	Andersone, D.
dc.authorsophos	Blanco, F.
dc.authorsophos	Yoo, D. H.
dc.authorsophos	Ahn, C.
dc.authorsophos	Kim, H. U.
dc.authorsophos	Braun, J.
dc.identifier.isi	331587903313
dc.identifier.sophos	11752
dc.issue.number	supl 3
dc.journal.title	Annals of the rheumatic diseases
dc.organization	Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de A Coruña::INIBIC.- Instituto de Investigación Biomédica
dc.page.initial	516
dc.page.final	517
dc.rights.accessRights	openAccess
dc.typesophos	Comunicaciones a congresos
dc.volume.number	72

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.